Company
Moonwalk Biosciences
Transforming obesity treatment
Also known as MOONWALK BIOSCIENCES, INC.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Legal name
- MOONWALK BIOSCIENCES, INC.
- moonwalk.bio (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Record updated 28 September 2026
About
Developing first-in-class, adipose-targeted RNA therapies that address the biology of cardiometabolic diseases
Funding snapshot
- Total raised
- $127MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Series B, $70M2026-09-08
Funding rounds
- Series B
- $70M2026-09-08, Company stated, 7 investors
- Round, 2023
- $49.6M2023-12-18, SEC form D sold, 24 investors